Analyst Activity – Royal Bank Of Canada Reiterates Hold on Endologix (NASDAQ:ELGX)

ME Staff
-
0

Analyst Ratings For Endologix (NASDAQ:ELGX)

Today, Royal Bank Of Canada reiterated its Hold rating on Endologix (NASDAQ:ELGX) with a price target of $5.00.

There are 9 hold ratings, 2 buy ratings on the stock.

The current consensus rating on Endologix (NASDAQ:ELGX) is Hold (Score: 2.18) with a consensus target price of $7.25 per share, a potential 43.00% upside.

Some recent analyst ratings include

  • 7/31/2017-Royal Bank Of Canada Reiterated Rating of Hold.
  • 6/5/2017-Stifel Nicolaus Reiterated Rating of Buy.
  • 5/18/2017-Oppenheimer Holdings, Inc. was Downgraded by analysts at Oppenheimer Holdings, Inc. from a “Outperform ” rating to a ” Market Perform” rating. They now have a $6.00 price target on the stock.
  • 5/18/2017-BMO Capital Markets Reiterated Rating of Hold.
  • 5/18/2017-Canaccord Genuity Reiterated Rating of Hold.
  • 5/18/2017-Stephens was Downgraded by analysts at Stephens from a “Overweight ” rating to a ” Equal Weight” rating. They now have a $6.00 price target on the stock.
  • 5/18/2017-BTIG Research was Downgraded by analysts at BTIG Research from a “Buy ” rating to a ” Neutral” rating. They now have a $7.00 price target on the stock.


  • On 5/22/2017 Dan Lemaitre, Director, bought 22,522 with an average share price of $4.43 per share and the total transaction amounting to $99,772.46. View SEC Filing
  • On 5/19/2017 Guido J Neels, Director, bought 20,000 with an average share price of $4.32 per share and the total transaction amounting to $86,400.00. View SEC Filing
  • On 5/19/2017 Robert D Mitchell, President, bought 2,200 with an average share price of $4.32 per share and the total transaction amounting to $9,504.00. View SEC Filing
  • On 12/14/2016 John D Mcdermott, CEO, bought 10,000 with an average share price of $6.67 per share and the total transaction amounting to $66,700.00. View SEC Filing
  • On 12/14/2016 Thomas F Zenty III, Director, bought 3,000 with an average share price of $6.51 per share and the total transaction amounting to $19,530.00. View SEC Filing
  • On 12/13/2016 Vaseem Mahboob, CFO, bought 20,000 with an average share price of $6.25 per share and the total transaction amounting to $125,000.00. View SEC Filing
  • On 11/18/2016 Guido J Neels, Director, bought 13,000 with an average share price of $7.69 per share and the total transaction amounting to $99,970.00. View SEC Filing

Recent Trading Activity for Endologix (NASDAQ:ELGX)
Shares of Endologix closed the previous trading session at 4.99 down -0.08 -1.48% with 381,627 shares trading hands.